Global Gabapentin Market Size Is Projected To Reach US$ 1716.2 Million By 2027, From US$ 1515 Million In 2020, At A CAGR Of 1.8% During 2021-2027

QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Gabapentin market in its latest report. All of the market forecasts presented in the report are authentic and reliable.

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. Global Gabapentin key players include Novartis, TEVA, Mylan, Pfizer, etc. Global top four manufacturers hold a share about 20%. North America is the largest market, with a share over 30%, followed by Asia-Pacific, and Europe, both have a share about 50 percent. In terms of product, Capsule is the largest segment, with a share about 55%. And in terms of application, the largest application is Epilepsy, followed by Neuropathic Pain, Restless Legs Syndrome, etc. Market Analysis and Insights: Global Gabapentin Market The global Gabapentin market size is projected to reach US$ 1716.2 million by 2027, from US$ 1515 million in 2020, at a CAGR of 1.8% during 2021-2027.

Request Sample Report and Full Report TOC: 

https://www.qyresearch.com/sample-form/form/3265968/global-gabapentin-market

The Essential Content Covered in the Global Gabapentin Market Report :

* Top Key Company Profiles.
* Main Business and Rival Information
* SWOT Analysis and PESTEL Analysis
* Production, Sales, Revenue, Price and Gross Margin
* Market Share and Size

Top Players of Gabapentin Market are Studied: Pfizer, Assertio Therapeutics, TEVA, Mylan, Arbor Pharma, Novartis, Apotex, Sun Pharmaceutical, Aurobindo Pharma, Intas, Amneal, Marksans Pharma, Glenmark, Alkem, Jiangsu Enhua, Jiangsu Hengrui, Sailike

The report provides a 6-year forecast (2021-2027) assessed based on how the Gabapentin market is predicted to grow in major regions like USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.

Segmentation by Type:  Capsule, Tablet

Segmentation by Application:  Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Others

Get Full Customize report or for any Special Discount visit@  
https://www.qyresearch.com/customize-request/form/3265968/global-gabapentin-market
Reasons to Buy this Report:

Industry Size & Forecast: Estimations on the global Gabapentin industry size on the basis of value and volume are provided in this part of the report
Study on Key Industry Trends: This section offers deep insights into the prevailing and upcoming Gabapentin trends
Segmental Analysis: Here, the report has examined the high-growth segments including product type, application, and end-users, taking into account their CAGR, share, and size
Future Prospects: Current Gabapentin developments and future opportunities estimated to emerge in the Gabapentin industry are looked into in this portion of the study
Geography-wise Analysis: The authors of the report have studied the regions having growth potential to help companies plan their future investments
Study on Competitive Landscape: The industry experts have offered thorough information about the strategic tactics adopted by the industry participants to consolidate their position. This assessment will help the players to strategize their activities in future.
Buy Now this Report at USD(3350):

https://www.qyresearch.com/settlement/pre/e03daea5f684c45eaca3de1155f682bf,0,1,global-gabapentin-market

TOC

1 Gabapentin Market Overview
1.1 Gabapentin Product Overview
1.2 Gabapentin Market Segment by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Global Gabapentin Market Size by Type
1.3.1 Global Gabapentin Market Size Overview by Type (2016-2027)
1.3.2 Global Gabapentin Historic Market Size Review by Type (2016-2021)

1.3.2.1 Global Gabapentin Sales Breakdown in Volume by Type (2016-2021)

1.3.2.2 Global Gabapentin Sales Breakdown in Value by Type (2016-2021)

1.3.2.3 Global Gabapentin Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Gabapentin Forecasted Market Size by Type (2022-2027)

1.3.3.1 Global Gabapentin Sales Breakdown in Volume by Type (2022-2027)

1.3.3.2 Global Gabapentin Sales Breakdown in Value by Type (2022-2027)

1.3.3.3 Global Gabapentin Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gabapentin Sales Breakdown by Type (2016-2021)
1.4.2 Europe Gabapentin Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Gabapentin Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Gabapentin Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Gabapentin Sales Breakdown by Type (2016-2021) 2 Global Gabapentin Market Competition by Company
2.1 Global Top Players by Gabapentin Sales (2016-2021)
2.2 Global Top Players by Gabapentin Revenue (2016-2021)
2.3 Global Top Players Gabapentin Price (2016-2021)
2.4 Global Top Manufacturers Gabapentin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gabapentin Market Competitive Situation and Trends
2.5.1 Gabapentin Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Gabapentin Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin as of 2020)
2.7 Date of Key Manufacturers Enter into Gabapentin Market
2.8 Key Manufacturers Gabapentin Product Offered
2.9 Mergers & Acquisitions, Expansion 3 Gabapentin Status and Outlook by Region
3.1 Global Gabapentin Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Gabapentin Historic Market Size by Region
3.2.1 Global Gabapentin Sales in Volume by Region (2016-2021)
3.2.2 Global Gabapentin Sales in Value by Region (2016-2021)
3.2.3 Global Gabapentin Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Gabapentin Forecasted Market Size by Region
3.3.1 Global Gabapentin Sales in Volume by Region (2022-2027)
3.3.2 Global Gabapentin Sales in Value by Region (2022-2027)
3.3.3 Global Gabapentin Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Gabapentin by Application
4.1 Gabapentin Market Segment by Application
4.1.1 Epilepsy
4.1.2 Neuropathic Pain
4.1.3 Restless Legs Syndrome
4.1.4 Others
4.2 Global Gabapentin Market Size by Application
4.2.1 Global Gabapentin Market Size Overview by Application (2016-2027)
4.2.2 Global Gabapentin Historic Market Size Review by Application (2016-2021)

4.2.2.1 Global Gabapentin Sales Breakdown in Volume, by Application (2016-2021)

4.2.2.2 Global Gabapentin Sales Breakdown in Value, by Application (2016-2021)

4.2.2.3 Global Gabapentin Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Gabapentin Forecasted Market Size by Application (2022-2027)

4.2.3.1 Global Gabapentin Sales Breakdown in Volume, by Application (2022-2027)

4.2.3.2 Global Gabapentin Sales Breakdown in Value, by Application (2022-2027)

4.2.3.3 Global Gabapentin Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gabapentin Sales Breakdown by Application (2016-2021)
4.3.2 Europe Gabapentin Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Gabapentin Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Gabapentin Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Gabapentin Sales Breakdown by Application (2016-2021) 5 North America Gabapentin by Country
5.1 North America Gabapentin Historic Market Size by Country
5.1.1 North America Gabapentin Sales in Volume by Country (2016-2021)
5.1.2 North America Gabapentin Sales in Value by Country (2016-2021)
5.2 North America Gabapentin Forecasted Market Size by Country
5.2.1 North America Gabapentin Sales in Volume by Country (2022-2027)
5.2.2 North America Gabapentin Sales in Value by Country (2022-2027) 6 Europe Gabapentin by Country
6.1 Europe Gabapentin Historic Market Size by Country
6.1.1 Europe Gabapentin Sales in Volume by Country (2016-2021)
6.1.2 Europe Gabapentin Sales in Value by Country (2016-2021)
6.2 Europe Gabapentin Forecasted Market Size by Country
6.2.1 Europe Gabapentin Sales in Volume by Country (2022-2027)
6.2.2 Europe Gabapentin Sales in Value by Country (2022-2027) 7 Asia-Pacific Gabapentin by Region
7.1 Asia-Pacific Gabapentin Historic Market Size by Region
7.1.1 Asia-Pacific Gabapentin Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Gabapentin Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Gabapentin Forecasted Market Size by Region
7.2.1 Asia-Pacific Gabapentin Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Gabapentin Sales in Value by Region (2022-2027) 8 Latin America Gabapentin by Country
8.1 Latin America Gabapentin Historic Market Size by Country
8.1.1 Latin America Gabapentin Sales in Volume by Country (2016-2021)
8.1.2 Latin America Gabapentin Sales in Value by Country (2016-2021)
8.2 Latin America Gabapentin Forecasted Market Size by Country
8.2.1 Latin America Gabapentin Sales in Volume by Country (2022-2027)
8.2.2 Latin America Gabapentin Sales in Value by Country (2022-2027) 9 Middle East and Africa Gabapentin by Country
9.1 Middle East and Africa Gabapentin Historic Market Size by Country
9.1.1 Middle East and Africa Gabapentin Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Gabapentin Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Gabapentin Forecasted Market Size by Country
9.2.1 Middle East and Africa Gabapentin Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Gabapentin Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Gabapentin Business
10.1 Pfizer
10.1.1 Pfizer Corporation Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Pfizer Gabapentin Products Offered
10.1.5 Pfizer Recent Development
10.2 Assertio Therapeutics
10.2.1 Assertio Therapeutics Corporation Information
10.2.2 Assertio Therapeutics Introduction and Business Overview
10.2.3 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Assertio Therapeutics Gabapentin Products Offered
10.2.5 Assertio Therapeutics Recent Development
10.3 TEVA
10.3.1 TEVA Corporation Information
10.3.2 TEVA Introduction and Business Overview
10.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.3.4 TEVA Gabapentin Products Offered
10.3.5 TEVA Recent Development
10.4 Mylan
10.4.1 Mylan Corporation Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Mylan Gabapentin Products Offered
10.4.5 Mylan Recent Development
10.5 Arbor Pharma
10.5.1 Arbor Pharma Corporation Information
10.5.2 Arbor Pharma Introduction and Business Overview
10.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Arbor Pharma Gabapentin Products Offered
10.5.5 Arbor Pharma Recent Development
10.6 Novartis
10.6.1 Novartis Corporation Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Novartis Gabapentin Products Offered
10.6.5 Novartis Recent Development
10.7 Apotex
10.7.1 Apotex Corporation Information
10.7.2 Apotex Introduction and Business Overview
10.7.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Apotex Gabapentin Products Offered
10.7.5 Apotex Recent Development
10.8 Sun Pharmaceutical
10.8.1 Sun Pharmaceutical Corporation Information
10.8.2 Sun Pharmaceutical Introduction and Business Overview
10.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Sun Pharmaceutical Gabapentin Products Offered
10.8.5 Sun Pharmaceutical Recent Development
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Corporation Information
10.9.2 Aurobindo Pharma Introduction and Business Overview
10.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Aurobindo Pharma Gabapentin Products Offered
10.9.5 Aurobindo Pharma Recent Development
10.10 Intas
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Gabapentin Product Category, Application and Specification
10.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Intas Recent Development
10.11 Amneal
10.11.1 Amneal Corporation Information
10.11.2 Amneal Introduction and Business Overview
10.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Amneal Gabapentin Products Offered
10.11.5 Amneal Recent Development
10.12 Marksans Pharma
10.12.1 Marksans Pharma Corporation Information
10.12.2 Marksans Pharma Introduction and Business Overview
10.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Marksans Pharma Gabapentin Products Offered
10.12.5 Marksans Pharma Recent Development
10.13 Glenmark
10.13.1 Glenmark Corporation Information
10.13.2 Glenmark Introduction and Business Overview
10.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Glenmark Gabapentin Products Offered
10.13.5 Glenmark Recent Development
10.14 Alkem
10.14.1 Alkem Corporation Information
10.14.2 Alkem Introduction and Business Overview
10.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Alkem Gabapentin Products Offered
10.14.5 Alkem Recent Development
10.15 Jiangsu Enhua
10.15.1 Jiangsu Enhua Corporation Information
10.15.2 Jiangsu Enhua Introduction and Business Overview
10.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Jiangsu Enhua Gabapentin Products Offered
10.15.5 Jiangsu Enhua Recent Development
10.16 Jiangsu Hengrui
10.16.1 Jiangsu Hengrui Corporation Information
10.16.2 Jiangsu Hengrui Introduction and Business Overview
10.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Jiangsu Hengrui Gabapentin Products Offered
10.16.5 Jiangsu Hengrui Recent Development
10.17 Sailike
10.17.1 Sailike Corporation Information
10.17.2 Sailike Introduction and Business Overview
10.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Sailike Gabapentin Products Offered
10.17.5 Sailike Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gabapentin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gabapentin Industrial Chain Analysis
11.4 Gabapentin Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gabapentin Distributors
12.3 Gabapentin Downstream Customers 13 Research Findings and Conclusion 14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

 
 

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry. 

This release was published on openPR.